ENTA Stock Summary and Trading Ideas (Enanta Pharmaceuticals | NASDAQ:ENTA)

Enanta Pharmaceuticals Inc is an American biotechnology company focused on the research and development of molecule drugs to cure viral infections and liver diseases. The targeted diseases are hepatitis C, hepatitis B, nonalcoholic steatohepatitis, and the respiratory syncytial virus. The novelty of company research is a specific direct-acting antiviral inhibitor against the hepatitis C virus. The company's inhibitors have been developed in collaboration with AbbVie. AbbVie markets the protease inhibitor, paritaprevir, while other inhibitors are in the pipeline.

Enanta Pharmaceuticals trades on the NASDAQ stock market under the symbol ENTA.

As of April 17, 2024, ENTA stock price declined to $14.00 with 186,810 million shares trading.

ENTA has a beta of 1.17, meaning it tends to be more sensitive to market movements. ENTA has a correlation of 0.04 to the broad based SPY ETF.

ENTA has a market cap of $296.18 million. This is considered a Small Cap stock.

Last quarter Enanta Pharmaceuticals reported $18 million in Revenue and -$1.58 earnings per share. This fell short of revenue expectation by $-3 million and missed earnings estimates by -$.39.

In the last 3 years, ENTA stock traded as high as $102.00 and as low as $8.08.

The top ETF exchange traded funds that ENTA belongs to (by Net Assets): VTI, IWM, VXF, IWN, SCHA.

ENTA has underperformed the market in the last year with a price return of -63.2% while the SPY ETF gained +22.5%. However, in the short term, ENTA had mixed performance relative to the market. It has outperformed in the last 3 months, returning +17.8% vs +6.3% return in SPY. But in the last 2 weeks, ENTA shares have been beat by the market, returning -16.2% compared to an SPY return of -3.6%.

ENTA support price is $14.69 and resistance is $16.03 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ENTA stock will trade within this expected range on the day.